39 results
424B3
EX-10.1
CMRA
Comera Life Sciences Holdings, Inc.
1 Sep 23
Prospectus supplement
4:33pm
Sciences Holdings, Inc. 2022 Equity and Incentive Plan (the “Plan”) are: (i) to provide long-term incentives and rewards to those employees, officers … ) who are in a position to contribute to the long-term success and growth of the Company and its Subsidiaries, (ii) to assist the Company and its
424B3
EX-10.1
CMRA
Comera Life Sciences Holdings, Inc.
1 Sep 23
Prospectus supplement
4:32pm
Sciences Holdings, Inc. 2022 Equity and Incentive Plan (the “Plan”) are: (i) to provide long-term incentives and rewards to those employees, officers … ) who are in a position to contribute to the long-term success and growth of the Company and its Subsidiaries, (ii) to assist the Company and its
8-K
EX-10.1
CMRA
Comera Life Sciences Holdings, Inc.
1 Sep 23
Departure of Directors or Certain Officers
4:31pm
Sciences Holdings, Inc. 2022 Equity and Incentive Plan (the “Plan”) are: (i) to provide long-term incentives and rewards to those employees, officers … ) who are in a position to contribute to the long-term success and growth of the Company and its Subsidiaries, (ii) to assist the Company and its
424B3
EX-10.1
CMRA
Comera Life Sciences Holdings, Inc.
1 Sep 23
Prospectus supplement
4:30pm
Sciences Holdings, Inc. 2022 Equity and Incentive Plan (the “Plan”) are: (i) to provide long-term incentives and rewards to those employees, officers … ) who are in a position to contribute to the long-term success and growth of the Company and its Subsidiaries, (ii) to assist the Company and its
DEF 14A
CMRA
Comera Life Sciences Holdings, Inc.
11 Aug 23
Definitive proxy
4:15pm
employees) who are in a position to contribute to our long-term success and growth, (ii) attract and retain persons with the requisite experience … or loss realized by the option holder on the subsequent sale of such shares is treated as long-term capital gain or loss for federal income tax purposes
PRE 14A
0jjq5lt
1 Aug 23
Preliminary proxy
5:08pm
424B3
40sufpu aix0e5
31 Mar 23
Prospectus supplement
4:34pm
424B3
bgvc9o7 syh
31 Mar 23
Prospectus supplement
4:34pm
424B3
jonps6htatu1pnf43n5
31 Mar 23
Prospectus supplement
4:32pm
424B3
s2apqw2 jgm
14 Nov 22
Prospectus supplement
5:19pm
424B3
uetw77uy a3
14 Nov 22
Prospectus supplement
5:15pm
424B3
ngmd27piz1j5wf9ibik
14 Nov 22
Prospectus supplement
5:09pm
424B3
py913ytwjet3xv
14 Nov 22
Prospectus supplement
4:50pm
8-K
EX-99.1
koksp4sd7 3ezmz
10 Nov 22
Comera Life Sciences Reports Financial Results for Third Quarter 2022 and Business Highlights
4:32pm
424B3
71km1hbi6
15 Sep 22
Prospectus supplement
4:09pm
424B3
u0jhxzyqxwok8mnaa0
2 Sep 22
Prospectus supplement
9:37pm
8-K
EX-99.1
cbnyl8vgz1w 9x
2 Sep 22
Other Events
9:32pm
424B3
EX-10.1
c51edoy4j0 oz3p8fr8
15 Aug 22
Prospectus supplement
5:45pm